Xenon Pharmaceuticals (XENE) Beats Q2 Earnings Estimates by $0.05
Earnings Results Xenon Pharmaceuticals (NASDAQ:XENE) reported quarterly earnings results on August 06, 2026 that exceeded analyst expectations. The Healthcare company reported…
Read more
